Selected research
Industry Research
Tumor MRD Detection Products and Services Industry Research Report 2026
Market perspective
The global Tumor MRD Detection Products and Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Tumor MRD Detection Products and Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Tumor MRD Detection Products and Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Tumor MRD Detection Products and Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Tumor MRD Detection Products and Services include Natera, Guardant Health, SeraCare Life Sciences, Inc. (LGC), Adaptive Biotechnologies, Invitae（ArcherDX）, Cergentis B.V., LexentBio(Foundation Medicine), Genecast and Genetron Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Tumor MRD Detection Products and Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tumor MRD Detection Products and Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tumor MRD Detection Products and Services Market by Company
Natera
Guardant Health
SeraCare Life Sciences, Inc. (LGC)
Adaptive Biotechnologies
Invitae（ArcherDX）
Cergentis B.V.
LexentBio(Foundation Medicine)
Genecast
Genetron Health
Acornmed
Shenzhen Neoimmune Co., Ltd.
Tung Tree Gene
Geneseeq
BGI Genomics
Burning Rock Biotech Limited
GenePlus
Tumor MRD Detection Products and Services Segment by Type
MRD Detection Products
In Vitro Diagnostic (IVD) Test Service
Tumor MRD Detection Products and Services Segment by Application
Lung Cancer
Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
Urinary System Tumors (Bladder Cancer)
Central Nervous System Tumors
Soft Tissue and Bone Tumors
Thyroid Cancer and Melanoma
Tumor MRD Detection Products and Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor MRD Detection Products and Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor MRD Detection Products and Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor MRD Detection Products and Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tumor MRD Detection Products and Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- MRD Detection Products
- In Vitro Diagnostic (IVD) Test Service
Applications
- Lung Cancer
- Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
- Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
- Urinary System Tumors (Bladder Cancer)
- Central Nervous System Tumors
- Soft Tissue and Bone Tumors
- Thyroid Cancer and Melanoma
Companies covered
- Natera
- Guardant Health
- SeraCare Life Sciences, Inc. (LGC)
- Adaptive Biotechnologies
- Invitae（ArcherDX）
- Cergentis B.V.
- LexentBio(Foundation Medicine)
- Genecast
- Genetron Health
- Acornmed
- Shenzhen Neoimmune Co., Ltd.
- Tung Tree Gene
- Geneseeq
- BGI Genomics
- Burning Rock Biotech Limited
- GenePlus
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tumor MRD Detection Products and Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 MRD Detection Products
- 2.2.3 In Vitro Diagnostic (IVD) Test Service
- 2.3 Tumor MRD Detection Products and Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Lung Cancer
- 2.3.3 Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
- 2.3.4 Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
- 2.3.5 Urinary System Tumors (Bladder Cancer)
- 2.3.6 Central Nervous System Tumors
- 2.3.7 Soft Tissue and Bone Tumors
- 2.3.8 Thyroid Cancer and Melanoma
- 2.4 Assumptions and Limitations
3 Tumor MRD Detection Products and Services Breakdown Data by Type
- 3.1 Global Tumor MRD Detection Products and Services Historic Market Size by Type (2021-2026)
- 3.2 Global Tumor MRD Detection Products and Services Forecasted Market Size by Type (2027-2032)
4 Tumor MRD Detection Products and Services Breakdown Data by Application
- 4.1 Global Tumor MRD Detection Products and Services Historic Market Size by Application (2021-2026)
- 4.2 Global Tumor MRD Detection Products and Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tumor MRD Detection Products and Services Market Perspective (2021-2032)
- 5.2 Global Tumor MRD Detection Products and Services Growth Trends by Region
- 5.2.1 Global Tumor MRD Detection Products and Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tumor MRD Detection Products and Services Historic Market Size by Region (2021-2026)
- 5.2.3 Tumor MRD Detection Products and Services Forecasted Market Size by Region (2027-2032)
- 5.3 Tumor MRD Detection Products and Services Market Dynamics
- 5.3.1 Tumor MRD Detection Products and Services Industry Trends
- 5.3.2 Tumor MRD Detection Products and Services Market Drivers
- 5.3.3 Tumor MRD Detection Products and Services Market Challenges
- 5.3.4 Tumor MRD Detection Products and Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tumor MRD Detection Products and Services Players by Revenue
- 6.1.1 Global Top Tumor MRD Detection Products and Services Players by Revenue (2021-2026)
- 6.1.2 Global Tumor MRD Detection Products and Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Tumor MRD Detection Products and Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tumor MRD Detection Products and Services Head Office and Area Served
- 6.4 Global Tumor MRD Detection Products and Services Players, Product Type & Application
- 6.5 Global Tumor MRD Detection Products and Services Manufacturers Established Date
- 6.6 Global Tumor MRD Detection Products and Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tumor MRD Detection Products and Services Market Size (2021-2032)
- 7.2 North America Tumor MRD Detection Products and Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 7.4 North America Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tumor MRD Detection Products and Services Market Size (2021-2032)
- 8.2 Europe Tumor MRD Detection Products and Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 8.4 Europe Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor MRD Detection Products and Services Market Size (2021-2032)
- 9.2 Asia-Pacific Tumor MRD Detection Products and Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tumor MRD Detection Products and Services Market Size (2021-2032)
- 10.2 South America Tumor MRD Detection Products and Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 10.4 South America Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor MRD Detection Products and Services Market Size (2021-2032)
- 11.2 Middle East & Africa Tumor MRD Detection Products and Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Natera
- 12.1.1 Natera Company Information
- 12.1.2 Natera Business Overview
- 12.1.3 Natera Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.1.4 Natera Tumor MRD Detection Products and Services Product Portfolio
- 12.1.5 Natera Recent Developments
- 12.2 Guardant Health
- 12.2.1 Guardant Health Company Information
- 12.2.2 Guardant Health Business Overview
- 12.2.3 Guardant Health Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.2.4 Guardant Health Tumor MRD Detection Products and Services Product Portfolio
- 12.2.5 Guardant Health Recent Developments
- 12.3 SeraCare Life Sciences, Inc. (LGC)
- 12.3.1 SeraCare Life Sciences, Inc. (LGC) Company Information
- 12.3.2 SeraCare Life Sciences, Inc. (LGC) Business Overview
- 12.3.3 SeraCare Life Sciences, Inc. (LGC) Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.3.4 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio
- 12.3.5 SeraCare Life Sciences, Inc. (LGC) Recent Developments
- 12.4 Adaptive Biotechnologies
- 12.4.1 Adaptive Biotechnologies Company Information
- 12.4.2 Adaptive Biotechnologies Business Overview
- 12.4.3 Adaptive Biotechnologies Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.4.4 Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio
- 12.4.5 Adaptive Biotechnologies Recent Developments
- 12.5 Invitae（ArcherDX）
- 12.5.1 Invitae（ArcherDX） Company Information
- 12.5.2 Invitae（ArcherDX） Business Overview
- 12.5.3 Invitae（ArcherDX） Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.5.4 Invitae（ArcherDX） Tumor MRD Detection Products and Services Product Portfolio
- 12.5.5 Invitae（ArcherDX） Recent Developments
- 12.6 Cergentis B.V.
- 12.6.1 Cergentis B.V. Company Information
- 12.6.2 Cergentis B.V. Business Overview
- 12.6.3 Cergentis B.V. Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.6.4 Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio
- 12.6.5 Cergentis B.V. Recent Developments
- 12.7 LexentBio(Foundation Medicine)
- 12.7.1 LexentBio(Foundation Medicine) Company Information
- 12.7.2 LexentBio(Foundation Medicine) Business Overview
- 12.7.3 LexentBio(Foundation Medicine) Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.7.4 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio
- 12.7.5 LexentBio(Foundation Medicine) Recent Developments
- 12.8 Genecast
- 12.8.1 Genecast Company Information
- 12.8.2 Genecast Business Overview
- 12.8.3 Genecast Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.8.4 Genecast Tumor MRD Detection Products and Services Product Portfolio
- 12.8.5 Genecast Recent Developments
- 12.9 Genetron Health
- 12.9.1 Genetron Health Company Information
- 12.9.2 Genetron Health Business Overview
- 12.9.3 Genetron Health Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.9.4 Genetron Health Tumor MRD Detection Products and Services Product Portfolio
- 12.9.5 Genetron Health Recent Developments
- 12.10 Acornmed
- 12.10.1 Acornmed Company Information
- 12.10.2 Acornmed Business Overview
- 12.10.3 Acornmed Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.10.4 Acornmed Tumor MRD Detection Products and Services Product Portfolio
- 12.10.5 Acornmed Recent Developments
- 12.11 Shenzhen Neoimmune Co., Ltd.
- 12.11.1 Shenzhen Neoimmune Co., Ltd. Company Information
- 12.11.2 Shenzhen Neoimmune Co., Ltd. Business Overview
- 12.11.3 Shenzhen Neoimmune Co., Ltd. Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.11.4 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio
- 12.11.5 Shenzhen Neoimmune Co., Ltd. Recent Developments
- 12.12 Tung Tree Gene
- 12.12.1 Tung Tree Gene Company Information
- 12.12.2 Tung Tree Gene Business Overview
- 12.12.3 Tung Tree Gene Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.12.4 Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio
- 12.12.5 Tung Tree Gene Recent Developments
- 12.13 Geneseeq
- 12.13.1 Geneseeq Company Information
- 12.13.2 Geneseeq Business Overview
- 12.13.3 Geneseeq Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.13.4 Geneseeq Tumor MRD Detection Products and Services Product Portfolio
- 12.13.5 Geneseeq Recent Developments
- 12.14 BGI Genomics
- 12.14.1 BGI Genomics Company Information
- 12.14.2 BGI Genomics Business Overview
- 12.14.3 BGI Genomics Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.14.4 BGI Genomics Tumor MRD Detection Products and Services Product Portfolio
- 12.14.5 BGI Genomics Recent Developments
- 12.15 Burning Rock Biotech Limited
- 12.15.1 Burning Rock Biotech Limited Company Information
- 12.15.2 Burning Rock Biotech Limited Business Overview
- 12.15.3 Burning Rock Biotech Limited Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.15.4 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio
- 12.15.5 Burning Rock Biotech Limited Recent Developments
- 12.16 GenePlus
- 12.16.1 GenePlus Company Information
- 12.16.2 GenePlus Business Overview
- 12.16.3 GenePlus Revenue in Tumor MRD Detection Products and Services Business (2021-2026)
- 12.16.4 GenePlus Tumor MRD Detection Products and Services Product Portfolio
- 12.16.5 GenePlus Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst